IFRX InflaRx NV: Earnings per share for the last twelve months
Compliance with ESG standards and sustainable bio-waste accounting confirm the reliability of the credit profile. This 12-month net income per share chart demonstrates stability, with the metric holding around 0.00. The financial cushion is bolstered by the diversification of clinical trials in oncology and a high level of trust from the medical community in the targeted developments of InflaRx N.V. (IFRX).
Analytical breakdowns and data insights for company InflaRx NV (IFRX)
- current quotes and average value forecast:
- company stock capitalization data:
- shareholders' equity book value data:
- debt and liquidity data:
- earnings and valuation multiples indicators:
IFRX - Company Net Income|Projected Future Earnings InflaRx N.V.|IFRX - P/E Multiple|Future Price to Earnings InflaRx GmbH|IFRX - Growth-Adjusted Payback Ratio|Enterprise Value to EBITDA Ratio InflaRx N.V.|IFRX - Operating profit before amortization|Net earnings per share for the last 12 months InflaRx|IFRX - Earnings per share for the trailing year|Year-over-year earnings per share growth for the last twelve months inflarx.de|IFRX - Earnings per share growth this year|Expected earnings per share growth for next year InflaRx N.V.
Fundamental company analysis:IFRX - inflarx.de
InflaRx N.V. specializes in developing complement inhibitors for the therapy of severe inflammatory processes in intensive care units. The company's annual net profit per share reflects the final financial result allocated to a single common share over a rolling period. This metric neutralizes the impact of share issuance, allowing for an assessment of actual profit generation efficiency. Positive dynamics in annual net profit per share confirm the scalability of the business model. The current trend determines the issuer's fair market capitalization.
Direct competitors
ARGX - Earnings per share for the last twelve months|biontech.de (BNTX) - Net earnings per share for the last 12 months|Abivax Pharma (ABVX) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months ADMA Biologics Inc|Net earnings per share for the last 12 months PTGX|Net earnings per share (EPS TTM) Immunovant Therapeutics|Earnings per share for the last twelve months Kiniksa Pharmaceuticals (KNSA)|grifols.com - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) ADPT (Adaptive Biotechnologies Corporation)|Celldex Therapeutics Inc (CLDX) - Net earnings per one share for the last twelve months|Aurinia Pharma - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters BioCryst Corp BCRX|Vera Therapeutics, Inc. (VERA) - Earnings per share for the last twelve months|Earnings per share for the last 12 months DNTH|PHVS (Pharvaris) - Net earnings per share (EPS TTM)|AbCellera Biologics Inc - Earnings per one share for the last 12 months|Earnings per share for the last twelve months Tourmaline Corp (TRML)|Earnings per share for the last twelve months PGEN (Precigen Corp)|Net earnings per share (EPS TTM) PHAR (Pharming Group N.V.)|Net earnings per share (EPS TTM) nektar.com NKTR|UPB - Earnings per share for the last twelve months|Earnings per share for the trailing year ZBIO (Zenas Bio)|IMNM (Immunome Corp) - Net earnings per share for the last 12 months|Earnings per share for the last 12 months GOSS|Net earnings per share for the last 12 months KALV|SEPN: Earnings per share for the trailing year|Earnings per share for the last twelve months Pieris Pharmaceuticals, Inc. (PVLA)|Savara Inc - Earnings per share for the last 12 months|Rigel Pharmaceuticals Inc - Net earnings per share for the last 12 months|Net earnings per share for the last four quarters AnaptysBio Inc. (ANAB)|ATXS: Net earnings per share for the last 12 months|ENGN: Earnings per share for the last twelve months|RAPT (RAPT Therapeutics, Inc.) - Net earnings per share for the last 12 months|JBIO - Net earnings per share for the last four quarters|ACRS (Aclaris) - Net earnings per share (EPS TTM)|Kyverna Therapeutics, Inc (KYTX) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) TLSA|CABA: Earnings per one share for the last 12 months|Earnings per share for the last twelve months Ventyx Biosciences, Inc. VTYX|Earnings per share for the trailing year THTX|AVTX: Net earnings per share for the last 12 months|ELDN (Eledon Pharmaceuticals, Inc) - Earnings per share for the last 12 months|Agenus (AGEN) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months CLYM (climbbio.com)|ZURA (Zura Bio Limited) - Net earnings per share (EPS TTM)|ATYR: Earnings per share for the trailing year|Net earnings per share (EPS TTM) ADAG|Net earnings per share (EPS TTM) ikenaoncology.com (IMA)|Earnings per share for the last twelve months Shattuck Labs STTK|Earnings per share for the trailing year EQ|CNTB - Earnings per share for the last twelve months|Immunic, Inc. (IMUX) - Net earnings per share for the last 12 months|ATRA: Net earnings per share (EPS TTM)|X4 Pharmaceuticals, Inc (XFOR) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months ACET|CELU: Earnings per share for the trailing year|Net earnings per share (EPS TTM) INMB|Net earnings per share for the last four quarters Barinthus Biotherapeutics PLC|Earnings per share for the last twelve months Kezar Life Sciences, Inc KZR|SABS - Net earnings per share for the last 12 months|AKTX - Earnings per share for the last twelve months|Enlivex Therapeutics (ENLV) - Net earnings per share for the last 12 months|QTTB (q32bio.com) - Net earnings per share for the last 12 months|GeoVax Labs (GOVX) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Edesa|Earnings per share for the last 12 months IBIO (iBio Corporation)|Net earnings per share (EPS TTM) CARM|XTLB - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) BOLT (Bolt Biotherapeutics, Inc.)|Net earnings per share for the last four quarters HCW Biologics, Inc. (HCWB)|APVO - Earnings per share for the last twelve months|AIM (AIM ImmunoTech, Inc.) - Earnings per share for the last 12 months|ADTX: Net earnings per share (EPS TTM)|Earnings per one share for the last 12 months GRI (gribio.com)|Earnings per share for the last twelve months XORTX Therapeutics|Earnings per share for the last twelve months HIND|Net earnings per share (EPS TTM) REVB|Net earnings per share (EPS TTM) Indaptus Corp (INDP)|Earnings per share for the last twelve months Scinai Immunotherapeutics SCNI|Earnings per share for the trailing year CALI|AFMD: Net earnings per share for the last 12 months|ALLK (Allakos Inc.) - Earnings per share for the last 12 months|HOOK (hookipapharma.com) - Net earnings per share for the last 12 months|IGM Biosciences - Earnings per share for the trailing year|Earnings per share for the last twelve months iTeos Therapeutics|Earnings per share for the last 12 months OCEA (oceanbiomedical.com)|Net earnings per share for the last 12 months TCBP (TC BioPharm)|Net earnings per share for the last four quarters Third Harmonic Bio Inc.
